Paediatric haematology,
oncology and haemostaseology
-
Prof. Dr. med. Thomas Klingebiel |
|
| |
> |
Expertise
|
|
> |
Resources
and Abilities
|
|
| |
| >
|
Publications
- Lehrnbecher T, Fleischhack
G, Hanisch M, Deinlein F,
Simon A, Bernig T, Chanock
SJ, Klingebiel T Circulating
levels and promoter polymorphisms
of IL-6 and IL-8 in pediatric
cancer patients with fever
and neutropenia. Haematologica
2004; 89:234-236
- Lehrnbecher T, Varwig D,
Kaiser J, Reinhardt D, Klingebiel
T, Creutzig U Infectious complications
in pediatric acute myeloid
leukemia: analysis of the
prospective multi-institutional
clinical trial AML-BFM 93.
Leukemia 2004; 18: 72-77
- Junker K, Koehl U, Zimmermann
S, Stein S, Schwabe D, Klingebiel
T, Grez M. Kinetics of cell
death in T lymphocytes genetically
modified with two novel suicide
fusion genes. Gene Ther 2003;10:1189-97
- Koehl U, Beck O, Esser R,
Seifried E, Klingebiel T,
Schwabe D, Seidl C. Quantitative
analysis of chimerism after
allogeneic stem cell transplantation
by PCR amplification of microsatellite
markers and capillary electrophoresis
with fluorescence detection:
The Frankfurt experience.
Leukemia 2003;1:232-6
- Koehl U, Zimmermann S, Esser
R, Sörensen J, Grüttner
HP, Duchscherer M, Seifried
E, Klingebiel T, Schwabe D.
Autologous transplantation
of CD133 selected haematopoietic
progenitor cells in a paediatric
patient with relapsed leukemia.
Bone Marrow Transplant 2002;29:927-30.
- Zimmermann S, Klingebiel
T, Koehl U, Sörensen
J, Schwabe D. Tecelac as antithymocyte
globulin in childhood allogeneic
stem cell transplantation.
Bone Marrow Transplant 2002;29:957-62
|
|
| |
> |
Staff:
- PD Dr. med. Dirk Schwabe
(klinische Studien)
- PD Dr. med. Thomas Lehrnbecher
(klinische Studien, Molekularbiologie)
- Dr. phil. nat. Ulrike Köhl
(Zelltherapie, Molekular-
und Zellbiologie, Pharmakokinetik)
|
| >
|
ZAFES-Coordinator:
|
|
|
